ArticleTrials2025

Efficacy and safety of nafamostat mesilate for sepsis (EASNMS): study protocol for a multicenter randomized controlled trial.

Hongyu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.